Arteris, Inc. President and CEO Janac K Charles filed a Form 4 with the SEC on November 4, 2026, disclosing the disposal of 99,000 shares of common stock on November 2, 2026, through Bayview Legacy, LLC under a pre-established 10b5-1 trading plan.
Key Highlights
- Two tranches disposed: 95,099 shares were sold at a weighted average price of $18.1856, and 4,901 shares were sold at a weighted average price of $18.8147, both on November 2, 2026.
- Price ranges disclosed: The first tranche covered prices from $17.72 to $18.71; the second covered prices from $18.72 to $19.05, per the filing's footnotes.
- 10b5-1 plan: Both transactions were made pursuant to a 10b5-1 trading plan adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on December 12, 2025.
- Indirect ownership vehicle: The shares were held and disposed of indirectly through Bayview Legacy, LLC, of which the reporting person is the manager and holds voting and dispositive power.
- Remaining beneficial ownership: Following the transactions, Bayview Legacy, LLC held 8,029,071 shares indirectly; additional holdings include 154,337 shares held directly and 56,252 shares held indirectly through the Charles and Lydia Janac Trust.
- Multiple roles: The filing identifies Janac K Charles as a Director, 10% Owner, and President and CEO of Arteris, Inc. (NASDAQ:AIP).
Arteris CEO Disposes of 99,000 Shares Through Bayview Legacy, LLC
According to the Form 4 filed on November 4, 2026, Janac K Charles, President and CEO of Arteris, Inc., disposed of a combined 99,000 shares of common stock on November 2, 2026. The shares were sold in two separate tranches through Bayview Legacy, LLC, an entity for which Charles serves as manager and holds both voting and dispositive authority over the shares it beneficially owns.
The first tranche consisted of 95,099 shares sold at a weighted average price of $18.1856, with individual transaction prices ranging from $17.72 to $18.71. The second tranche of 4,901 shares was sold at a weighted average price of $18.8147, with prices ranging from $18.72 to $19.05. The filing notes that full per-share transaction details are available upon request to the issuer, any security holder, or SEC staff.
Arteris, Inc. is a semiconductor intellectual property company. The transactions were executed pursuant to a Rule 10b5-1 trading plan that was adopted on December 12, 2025, by K. Charles Janac in his capacity as manager of Bayview Legacy, LLC. Following the reported sales, the filing discloses that Bayview Legacy, LLC held 8,029,071 shares indirectly. Charles also holds 154,337 shares directly and 56,252 shares indirectly through the Charles and Lydia Janac Trust, for which he serves as trustee.
What Was Disclosed
The filing reports two disposals of Arteris common stock totaling 99,000 shares on November 2, 2026, by President and CEO Janac K Charles through Bayview Legacy, LLC, carried out under a 10b5-1 plan adopted December 12, 2025.




Please wait processing your request...